A detailed history of Ubs Group Ag transactions in Equillium, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 19,351 shares of EQ stock, worth $11,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,351
Previous 6,287 207.79%
Holding current value
$11,804
Previous $4,000 300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.64 - $1.13 $8,360 - $14,762
13,064 Added 207.79%
19,351 $16,000
Q2 2024

Aug 13, 2024

BUY
$0.66 - $2.33 $4,149 - $14,648
6,287 New
6,287 $4,000
Q1 2023

May 12, 2023

SELL
$0.56 - $1.24 $4,762 - $10,544
-8,504 Reduced 58.46%
6,043 $4,000
Q4 2022

Feb 08, 2023

BUY
$0.83 - $2.26 $10,278 - $27,987
12,384 Added 572.54%
14,547 $15,000
Q3 2022

Nov 10, 2022

BUY
$1.93 - $3.14 $3,016 - $4,907
1,563 Added 260.5%
2,163 $5,000
Q2 2022

Aug 10, 2022

SELL
$1.69 - $3.26 $2,095 - $4,042
-1,240 Reduced 67.39%
600 $1,000
Q1 2022

May 16, 2022

BUY
$2.99 - $4.19 $5,501 - $7,709
1,840 New
1,840 $6,000
Q3 2021

Nov 15, 2021

SELL
$4.84 - $6.91 $2,570 - $3,669
-531 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$5.11 - $7.64 $843 - $1,260
-165 Reduced 23.71%
531 $3,000
Q1 2021

May 12, 2021

SELL
$5.03 - $10.5 $121,454 - $253,533
-24,146 Reduced 97.2%
696 $5,000
Q4 2020

Feb 11, 2021

BUY
$3.48 - $6.58 $86,450 - $163,460
24,842 New
24,842 $133,000
Q3 2020

Nov 12, 2020

SELL
$2.78 - $26.5 $6,819 - $65,004
-2,453 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$2.34 - $3.53 $5,740 - $8,659
2,453 New
2,453 $7,000
Q1 2020

May 01, 2020

SELL
$2.3 - $5.5 $3,077 - $7,359
-1,338 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$3.0 - $5.0 $5,487 - $9,145
-1,829 Reduced 57.75%
1,338 $5,000
Q3 2019

Nov 14, 2019

BUY
$3.31 - $5.6 $7,493 - $12,678
2,264 Added 250.72%
3,167 $12,000
Q2 2019

Aug 14, 2019

BUY
$5.28 - $8.2 $4,767 - $7,404
903 New
903 $5,000
Q1 2019

May 14, 2019

SELL
$5.84 - $12.02 $11,154 - $22,958
-1,910 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$6.32 - $19.44 $12,071 - $37,130
1,910 New
1,910 $16,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $21M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.